Valuation: Three Routes, One Question
Valuation puts a number on a business by one of three routes: discounting its future cash, applying a multiple from comparable companies, or totalling its assets. The three routinely disagree, and the size of the disagreement is more informative than any single answer.
How it works
Three routes exist and everything else is a variation. Discount the future cash, apply a multiple taken from similar companies, or add up what the business owns.
A multiple is a compressed discounted cash flow. Fourteen times earnings embeds assumptions about growth, risk and duration; it just does not make you state them.
Price to earnings is the most common and the least careful. It ignores the balance sheet entirely, so two companies with identical operations and different debt levels look comparable when they are not.
Getting the comparison right
Enterprise value is the fix. Market capitalisation plus debt minus cash is what it would cost to buy the whole business, and it is the figure that makes leveraged and unleveraged companies comparable.
A comparable has to be genuinely comparable. Same industry is not enough — growth rate, margin structure and capital intensity all have to be close, or the multiple is being borrowed from a different business.
The cyclical trap is the one that catches people repeatedly. A cyclical business looks cheapest at the top of its cycle, because earnings are at a peak that will not repeat — so the low multiple is a warning rather than an opportunity.
Adjusted earnings lower every multiple mechanically. A larger denominator produces a smaller ratio, and the adjustments are defined by the company. Use the reported figure or state clearly which adjustments you accepted and why.
In practice: run all three
Asset value sets a floor. What the business would fetch broken up — usually well below any going-concern figure, and useful mainly as a sanity check on how much of the valuation depends on the business continuing to trade.
Growth justifies a premium and the premium is a forecast. A multiple pricing in fifteen per cent growth against a business delivering six is a specific, checkable claim rather than a matter of opinion.
Disagreement between the methods is diagnostic. A large gap between the cash-flow figure and the asset figure says the value depends almost entirely on future performance, which is a specific risk you can then decide whether to take.
A precise valuation is a warning sign. The inputs are estimates, so the output is a range; a figure quoted to the penny reflects a spreadsheet’s arithmetic rather than anybody’s knowledge.
None of it has a timing component. A correct valuation can sit uncorrected for years, which is the practical difference between being right and making money.
There is a fourth route worth knowing even though it is rarely available: what somebody actually paid. Recent acquisitions of similar businesses give a real transaction price rather than a modelled one, and a buyer who had to fund the purchase has revealed more than any analyst estimate does.
The limitation is that acquisition prices include a control premium. A buyer taking the whole company pays more per share than the market price, because control is worth something a minority stake is not. Deduct that premium before comparing a deal price with a share price, or the comparison flatters every listed company in the sector by the same amount.
What valuation is not
It is not a price prediction. It says nothing about when.
It is not one number. Three methods, three answers, one range.
It is not objective. Every input is a judgement about the future.
And it is not a substitute for understanding the business.
When it fails
It fails on businesses without a history. Every method needs something to extrapolate from, and a company two years old with no profit provides nothing except a story and a multiple borrowed from somewhere else.
The second failure is a peer group chosen to flatter. Comparables are selected, and the selection is where the conclusion usually enters.
A third is ignoring the capital structure. Price to earnings on a heavily indebted company is not comparable with the same ratio on a debt-free one.
A fourth is valuing on adjusted figures. They are unaudited and defined by the company being valued.
And a fifth is treating a valuation as a decision. It is one input; position size, timing and what else you own are separate questions it does not address.
The original data
Of the 31,760 trading and investing videos in this site’s corpus, 9 have “valuation” in the title at a
median of 17,868 views across 7 channels, with a maximum of 2,608,227. “Intrinsic value” returns 1 at
1,019,621 views, “discounted cash flow” returns 1 at 143,078, and “financial statements” returns 3 at a
median of 1,065,893. The counts are in research/corpus-coverage.json, produced by
site/measure_corpus.py.
The figures in the diagrams on this page are illustrative. The three methods giving 2,020, 1,750 and 1,100 on the same business is not an exaggeration — a spread of that size between a cash-flow estimate and an asset estimate is ordinary, and it is the spread rather than any one figure that tells you what the investment actually depends on.
Nine videos at a median of 17,868 views, against hundreds of indicator tutorials at a median in the low thousands, is the demand pattern across this whole subject. Fewer people teach it and more people watch each one. Run all three methods before forming a view, and record the range rather than the midpoint — it takes an afternoon and it is the difference between a valuation and a justification.
Related
Intrinsic value is what the methods are estimating. Discounted cash flow is the most explicit of the three. And financial statements is where every input comes from.
The mistake I made for years was picking the method that gave me the answer I wanted and calling it analysis. Running all three and looking at the spread was the change. When they agree I have something; when they are far apart, the disagreement is telling me which assumption the whole case rests on.
— Michael Whitman
This page is educational, not financial advice. Test every idea on your own charts before risking money.